☆ 3.8 Editorial Material

Phase II Study of Pembrolizumab (MK-3475) in Patients with metastatic castration-resistant Prostate Cancer (KEYNOTE-199)-Study AP 93/16 of the AUO

UROLOGE (2017)

Get Full Text
Add to Collection

Journal

UROLOGE
Volume 56, Issue 11, Pages 1471-1472

Publisher

SPRINGER HEIDELBERG
DOI: 10.1007/s00120-017-0519-9

Keywords

-

Categories

Urology & Nephrology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.